Correlation Between Cns Pharmaceuticals and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Cns Pharmaceuticals and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Acumen Pharmaceuticals.
Diversification Opportunities for Cns Pharmaceuticals and Acumen Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cns and Acumen is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Acumen Pharmaceuticals
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 1.17 times more return on investment than Acumen Pharmaceuticals. However, Cns Pharmaceuticals is 1.17 times more volatile than Acumen Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 14.00 in Cns Pharmaceuticals on August 28, 2024 and sell it today you would lose (2.00) from holding Cns Pharmaceuticals or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Acumen Pharmaceuticals |
Cns Pharmaceuticals and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Acumen Pharmaceuticals
The main advantage of trading using opposite Cns Pharmaceuticals and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
| Acumen Pharmaceuticals vs. Eliem Therapeutics | Acumen Pharmaceuticals vs. Scpharmaceuticals | Acumen Pharmaceuticals vs. Milestone Pharmaceuticals | Acumen Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |